Current treatment options for acanthosis nigricans.

Clin Cosmet Investig Dermatol

Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC,

Published: August 2018

Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes causing the velvety, hyperpigmented, hyperkeratotic plaques found on the skin. While the goal of therapy is to treat the primary cause, cosmetic resolution of AN lesions can be important for patients and their quality of life. Treatment options for AN have not been extensively studied; however, smaller powered clinical trials and case reports exist in the literature. Our review aims to explore and evaluate the current treatment options that exist for AN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086114PMC
http://dx.doi.org/10.2147/CCID.S137527DOI Listing

Publication Analysis

Top Keywords

treatment options
12
current treatment
8
acanthosis nigricans
8
options acanthosis
4
nigricans acanthosis
4
nigricans common
4
common dermatologic
4
dermatologic manifestation
4
manifestation systemic
4
systemic disease
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!